Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshyaya Pradhan

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
World Journal of Cardiology|April 5, 2024
Predictors of permanent pacemaker implantation following transcatheter aortic valve replacement-the search is still on!Sudesh Prajapathi, Akshyaya Pradhan
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|December 16, 2024
Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney diseaseAkshyaya Pradhan, Umesh Chandra Tripathi
Cardiology Research and Practice|July 17, 2020
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and PerspectivesAkshyaya Pradhan, Monika Bhandari, Rishi Sethi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|December 2, 2021
A "20/20" Match: ACC/AHA 2017 versus ESC/ESH 2018 Guidelines for Management of HypertensionAkshyaya Pradhan, Shweta Vohra, Rishi Sethi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|August 30, 2018
Landmark Trials in Cardiology in 2017-Celebrating 40 Years of AngioplastyAkshyaya Pradhan, Pravesh Vishwakarma, Rishi Sethi
Journal of Family Medicine and Primary Care|August 30, 2019
Fimasartan: A new armament to fight hypertensionAkshyaya Pradhan, Vikas Gupta, Rishi Sethi
Cardiac Failure Review|November 26, 2024
Evidence for Aldosterone Antagonism in Heart FailureRishi Sethi, Pravesh Vishwakarma, Akshyaya Pradhan
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|March 1, 2026
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatmentSajeet Verma, Akshyaya Pradhan, Prashant Thandi
Journal of Family Medicine and Primary Care|December 4, 2024
TRANSFORM-HF Trial: Choice of loop diuretic in acute heart failure does not matter!Akshyaya Pradhan, Arvind Jaiswal, Monika Bhandari
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|February 13, 2025
The Year in Cardiology-Practice Changing Trials from European Society of Cardiology Congress 2023Akshyaya Pradhan, Umesh Tripathi, Abhishek Singh
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
World Journal of Cardiology|April 5, 2024
Predictors of permanent pacemaker implantation following transcatheter aortic valve replacement-the search is still on!Sudesh Prajapathi, Akshyaya Pradhan
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|December 16, 2024
Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney diseaseAkshyaya Pradhan, Umesh Chandra Tripathi
Cardiology Research and Practice|July 17, 2020
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and PerspectivesAkshyaya Pradhan, Monika Bhandari, Rishi Sethi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|December 2, 2021
A "20/20" Match: ACC/AHA 2017 versus ESC/ESH 2018 Guidelines for Management of HypertensionAkshyaya Pradhan, Shweta Vohra, Rishi Sethi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|August 30, 2018
Landmark Trials in Cardiology in 2017-Celebrating 40 Years of AngioplastyAkshyaya Pradhan, Pravesh Vishwakarma, Rishi Sethi
Journal of Family Medicine and Primary Care|August 30, 2019
Fimasartan: A new armament to fight hypertensionAkshyaya Pradhan, Vikas Gupta, Rishi Sethi
Cardiac Failure Review|November 26, 2024
Evidence for Aldosterone Antagonism in Heart FailureRishi Sethi, Pravesh Vishwakarma, Akshyaya Pradhan
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|March 1, 2026
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatmentSajeet Verma, Akshyaya Pradhan, Prashant Thandi
Journal of Family Medicine and Primary Care|December 4, 2024
TRANSFORM-HF Trial: Choice of loop diuretic in acute heart failure does not matter!Akshyaya Pradhan, Arvind Jaiswal, Monika Bhandari
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|February 13, 2025
The Year in Cardiology-Practice Changing Trials from European Society of Cardiology Congress 2023Akshyaya Pradhan, Umesh Tripathi, Abhishek Singh
Pageof 15